Evelo Biosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch EVLO and buy or sell other stocks, ETFs, and their options commission-free!

About EVLO

Evelo Biosciences, Inc. operates as a clinical stage biotechnology company, which engages in the development of orally delivered investigational medicines. Its portfolio includes EDP1066 and EDP1815 for the treatment of inflammatory diseases, EDP2939 for inflammation, and EDP1908 for oncology. 

CEO
Balkrishan Gill
CEOBalkrishan Gill
Employees
66
Employees66
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2014
Founded2014
Employees
66
Employees66

EVLO Key Statistics

Market cap
57.03K
Market cap57.03K
Price-Earnings ratio
-3.13
Price-Earnings ratio-3.13
Dividend yield
—
Dividend yield—
Average volume
43.16M
Average volume43.16M
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$3.29
52 Week high$3.29
52 Week low
$0.0243
52 Week low$0.0243

People also own

Based on the portfolios of people who own EVLO. This list is generated using Robinhood data, and it’s not a recommendation.
Mullen Automotive
Ideanomics
Nikola
Ocugen, Inc
Faraday Future Intelligen…
Cenntro Electric Group Li…
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.